<VariationArchive VariationID="36849" VariationName="NM_000458.4(HNF1B):c.477del (p.Pro159_Met160insTer)" VariationType="Deletion" Accession="VCV000036849" Version="10" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="45510" VariationID="36849">
      <GeneList>
        <Gene Symbol="HNF1B" FullName="HNF1 homeobox B" GeneID="6928" HGNC_ID="HGNC:11630" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="37686431" stop="37745059" display_start="37686431" display_stop="37745059" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NT_187614.1" start="1925499" stop="1984115" display_start="1925499" display_stop="1984115" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="36046433" stop="36105095" display_start="36046433" display_stop="36105095" Strand="-" />
          </Location>
          <OMIM>189907</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HNF1B">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HNF1B">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000458.4(HNF1B):c.477del (p.Pro159_Met160insTer)</Name>
      <CanonicalSPDI>NC_000017.11:37739506:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="37739507" stop="37739507" display_start="37739507" display_stop="37739507" variantLength="1" positionVCF="37739506" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="36099498" stop="36099498" display_start="36099498" display_stop="36099498" variantLength="1" positionVCF="36099497" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.36099498del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.36099498del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.37739507del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.37739507del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013019.2" sequenceAccession="NG_013019" sequenceVersion="2" change="g.10600del">
            <Expression>NG_013019.2:g.10600del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000458.4" sequenceAccession="NM_000458" sequenceVersion="4" change="c.477del" MANESelect="true">
            <Expression>NM_000458.4:c.477del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000449.1" sequenceAccession="NP_000449" sequenceVersion="1" change="p.Pro159_Met160insTer">
            <Expression>NP_000449.1:p.Pro159_Met160insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001165923.4" sequenceAccession="NM_001165923" sequenceVersion="4" change="c.477del">
            <Expression>NM_001165923.4:c.477del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159395.1" sequenceAccession="NP_001159395" sequenceVersion="1" change="p.Pro159_Met160insTer">
            <Expression>NP_001159395.1:p.Pro159_Met160insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001304286.2" sequenceAccession="NM_001304286" sequenceVersion="2" change="c.477del">
            <Expression>NM_001304286.2:c.477del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001291215.1" sequenceAccession="NP_001291215" sequenceVersion="1" change="p.Pro159_Met160insTer">
            <Expression>NP_001291215.1:p.Pro159_Met160insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000458.3" sequenceAccession="NM_000458" sequenceVersion="3" change="c.477delT">
            <Expression>NM_000458.3:c.477delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA214360" DB="ClinGen" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000458.4(HNF1B):c.477del (p.Pro159_Met160insTer) AND Renal cysts and diabetes syndrome" Accession="RCV000030530" Version="9">
        <ClassifiedConditionList TraitSetID="3435">
          <ClassifiedCondition DB="MedGen" ID="C0431693">Renal cysts and diabetes syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-09-02" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000458.4(HNF1B):c.477del (p.Pro159_Met160insTer) AND multiple conditions" Accession="RCV002477029" Version="3">
        <ClassifiedConditionList TraitSetID="11913">
          <ClassifiedCondition DB="MedGen" ID="CN074294">Nonpapillary renal cell carcinoma</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0431693">Renal cysts and diabetes syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0011860">Type 2 diabetes mellitus</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000458.4(HNF1B):c.477del (p.Pro159_Met160insTer) AND not provided" Accession="RCV002513268" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-02" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2013-04-04" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="DOI">10.1101/576918</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11085914</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11845238</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12148114</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15068978</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15509593</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18528323</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20378641</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24429398</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25536396</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25700310</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30259503</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33305128</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9398836</ID>
        </Citation>
        <DescriptionHistory Dated="2019-07-13">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="11913" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4321" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial hypoplastic, glomerulocystic kidney</ElementValue>
                <XRef ID="253864004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MODY type 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Renal cysts and diabetes syndrome</ElementValue>
                <XRef ID="MONDO:0007669" DB="MONDO" />
                <XRef ID="vr002" DB="NCBI for submitter" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperuricemic nephropathy, familial juvenile, atypical</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FJHN atypical</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glomerulocystic kidney disease, hypoplastic type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Maturity-onset diabetes of the young, type 5</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RCAD</ElementValue>
                <XRef Type="MIM" ID="137920" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MODY5</ElementValue>
                <XRef Type="MIM" ID="137920" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The 17q12 recurrent deletion syndrome is characterized by variable combinations of the three following findings: structural or functional abnormalities of the kidney and urinary tract, maturity-onset diabetes of the young type 5 (MODY5), and neurodevelopmental or neuropsychiatric disorders (e.g., developmental delay, intellectual disability, autism spectrum disorder, schizophrenia, anxiety, and bipolar disorder). Using a method of data analysis that avoids ascertainment bias, the authors determined that multicystic kidneys and other structural and functional kidney anomalies occur in 85% to 90% of affected individuals, MODY5 in approximately 40%, and some degree of developmental delay or learning disability in approximately 50%. MODY5 is most often diagnosed before age 25 years (range: age 10-50 years).</Attribute>
                <XRef ID="NBK401562" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10221" />
                <XRef ID="10221" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27929632</ID>
                <ID Source="BookShelf">NBK401562</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29792621</ID>
                <ID Source="BookShelf">NBK500456</ID>
              </Citation>
              <XRef ID="93111" DB="Orphanet" />
              <XRef ID="C0431693" DB="MedGen" />
              <XRef ID="MONDO:0007669" DB="MONDO" />
              <XRef Type="MIM" ID="137920" DB="OMIM" />
            </Trait>
            <Trait ID="15944" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nonpapillary renal cell carcinoma</ElementValue>
                <XRef ID="HP:0006770" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0007763" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">RCC</ElementValue>
                <XRef Type="MIM" ID="144700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <XRef ID="422526" DB="Orphanet" />
              <XRef ID="CN074294" DB="MedGen" />
              <XRef ID="MONDO:0007763" DB="MONDO" />
              <XRef Type="MIM" ID="144700" DB="OMIM" />
            </Trait>
            <Trait ID="4949" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Type 2 diabetes mellitus</ElementValue>
                <XRef ID="Diabetes+mellitus+type+2/8215" DB="Genetic Alliance" />
                <XRef ID="HP:0005978" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005148" DB="MONDO" />
                <XRef ID="44054006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST</ElementValue>
                <XRef ID="125853" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Type II diabetes mellitus</ElementValue>
                <XRef ID="HP:0005978" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diabetes mellitus, noninsulin-dependent, late onset</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">T2D</ElementValue>
                <XRef Type="MIM" ID="125853" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NIDDM</ElementValue>
                <XRef ID="HP:0005978" DB="Human Phenotype Ontology" />
                <XRef Type="MIM" ID="125853" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301750</ID>
                <ID Source="BookShelf">NBK4144</ID>
              </Citation>
              <Citation Type="general" Abbrev="PLoS Currents, 2011">
                <URL>http://knol.google.com/k/raluca-mihaescu/genetic-risk-profiling-for-prediction/20113liwenx5c/9?collectionId=28qm4w0q65e4w.50#</URL>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2013">
                <ID Source="PubMed">23492873</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2012">
                <ID Source="PubMed">22962670</ID>
                <ID Source="pmc">3431581</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/cg181</URL>
                <CitationText>UK NICE Guidance, Clinical Guideline CG181, Cardiovascular disease: risk assessment and reduction, including lipid modification, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng18</URL>
                <CitationText>UK NICE Guideline NG18, Diabetes (type 1 and type 2) in children and young people: diagnosis and management, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/ng28</URL>
                <CitationText>UK NICE Guideline NG28, Type 2 diabetes in adults: management, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng136</URL>
                <CitationText>UK NICE Guideline NG136, Hypertension in adults: diagnosis and management, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/ng3</URL>
                <CitationText>UK NICE Guideline NG3, Diabetes in pregnancy: management from preconception to the postnatal period</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2019">
                <URL>https://www.nice.org.uk/guidance/ng19</URL>
                <CitationText>UK NICE Guideline NG19, Diabetic foot problems: prevention and management, 2019</CitationText>
              </Citation>
              <XRef ID="C0011860" DB="MedGen" />
              <XRef ID="D003924" DB="MeSH" />
              <XRef ID="MONDO:0005148" DB="MONDO" />
              <XRef Type="MIM" ID="125853" DB="OMIM" />
              <XRef Type="primary" ID="HP:0005978" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005965" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0100652" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3435" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4321" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial hypoplastic, glomerulocystic kidney</ElementValue>
                <XRef ID="253864004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MODY type 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Renal cysts and diabetes syndrome</ElementValue>
                <XRef ID="MONDO:0007669" DB="MONDO" />
                <XRef ID="vr002" DB="NCBI for submitter" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperuricemic nephropathy, familial juvenile, atypical</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FJHN atypical</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glomerulocystic kidney disease, hypoplastic type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Maturity-onset diabetes of the young, type 5</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RCAD</ElementValue>
                <XRef Type="MIM" ID="137920" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MODY5</ElementValue>
                <XRef Type="MIM" ID="137920" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The 17q12 recurrent deletion syndrome is characterized by variable combinations of the three following findings: structural or functional abnormalities of the kidney and urinary tract, maturity-onset diabetes of the young type 5 (MODY5), and neurodevelopmental or neuropsychiatric disorders (e.g., developmental delay, intellectual disability, autism spectrum disorder, schizophrenia, anxiety, and bipolar disorder). Using a method of data analysis that avoids ascertainment bias, the authors determined that multicystic kidneys and other structural and functional kidney anomalies occur in 85% to 90% of affected individuals, MODY5 in approximately 40%, and some degree of developmental delay or learning disability in approximately 50%. MODY5 is most often diagnosed before age 25 years (range: age 10-50 years).</Attribute>
                <XRef ID="NBK401562" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10221" />
                <XRef ID="10221" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27929632</ID>
                <ID Source="BookShelf">NBK401562</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29792621</ID>
                <ID Source="BookShelf">NBK500456</ID>
              </Citation>
              <XRef ID="93111" DB="Orphanet" />
              <XRef ID="C0431693" DB="MedGen" />
              <XRef ID="MONDO:0007669" DB="MONDO" />
              <XRef Type="MIM" ID="137920" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5426783" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000458.4:c.477del|OMIM:125853;137920;144700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002777640" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000458.4:c.477del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="125853" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="137920" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="144700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6132179" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4940496|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003443072" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11085914</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24429398</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9398836</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12148114</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15068978</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20378641</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 36849). This variant is also known as P159fsdelT. This premature translational stop signal has been observed in individual(s) with clinical features of HNF1B-related conditions (PMID: 11085914, 24429398). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Met160*) in the HNF1B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HNF1B are known to be pathogenic (PMID: 9398836, 12148114, 15068978, 20378641).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.36099498del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5414725" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_000458_3_HNF1B_c_477delT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002766951" DateUpdated="2024-07-23" DateCreated="2022-12-24" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11085914</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11845238</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15509593</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25536396</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30259503</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33305128</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Dominant negative, loss of function, and gain of function are all reported mechanisms of disease in this gene and are associated with type 2 diabetes mellitus (MIM#125853) and renal cysts and diabetes syndrome (MIM#137920; OMIM, PMID: 25536396, 11845238, 15509593). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity. There is significant interfamilial and intrafamilial variability of HNF1B-related nephropathy (PMID: 33305128). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. These variants have been reported many times as pathogenic (DECIPHER). (SP) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been reported as pathogenic, and observed in indidivuals with diabetes mellitus, noninsulin-dependent (MODY) or glomerulocystic kidney disease (ClinVar, PMID: 11085914, PMID: 30259503). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_15762</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000458.3:c.477delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="137920" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1811300" SubmissionDate="2019-07-07" DateLastUpdated="2019-07-14" DateCreated="2019-07-14">
        <ClinVarSubmissionID localKey="vr151|MedGen:CN206512" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000926130" DateUpdated="2019-07-14" DateCreated="2019-07-14" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, FAU Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg" OrgID="505150" OrganizationCategory="laboratory" OrgAbbreviation="IoHGE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25700310</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11085914</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24429398</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11085914</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30259503</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25536396</ID>
          </Citation>
          <Citation>
            <ID Source="DOI">10.1101/576918</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000458.3:c.477del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Renal cysts and diabetes syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN206512" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="DOI">10.1101/576918</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="DOI">10.1101/576918</ID>
        </Citation>
        <Comment>This variant and it's classification has been reported by Vasileiou et al. 2019; DOI:10.1101/576918. The variants has previously been reported in ClinVar:12639; ClinVar:36849; PMID:25700310; PMID:11085914; PMID:24429398; PMID:11085914; PMID:30259503; PMID:25536396 as "HNF1B, 1-BP DEL (P159fsdelT); NM_000458.3(HNF1B):c.477delT (p.Met160Terfs); c.477delT; c.477delT p.M160*; c.477delT p.Met160Terfs; c.477delT" with clinical significance Pathogenic; Likely pathogenic. It has been re-classified using InterVar and manual curation as Pathogenic based on PVS1 PM2 PP3.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB5920232</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="57351" SubmissionDate="2011-08-18" DateLastUpdated="2022-04-07" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="TCF2_477delT_101910" title="TCF2:c.477delT and MODY5/RCAD" />
        <ClinVarAccession Accession="SCV000053201" DateUpdated="2022-04-07" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-08-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">18528323</ID>
          </Citation>
          <Comment>Converted during submission to Likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">autosomal dominant</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>2</NumberTested>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
              <Citation Type="general">
                <ID Source="PubMed">11085914</ID>
              </Citation>
              <Comment>Variant found in son and mother in this family in het state, both the affected subjects have renal impairment and small kidneys with cortical cysts visualized on ultra sound scanning and calyceal abnormalities on IVU, Mother II-2 has shown cortical glomerular cysts and glomerular tufts, and was diagnosed as having diabetes at age 39, Son III-1 found to have impaired glucose intolerance on an oral glucose-tolerance test performed at age 17 yrs, It presents the clear case of coseggregation , Not found in Controls see PbGP.</Comment>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Tissue>Blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>assert pathogenicity</Purpose>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles">1</Attribute>
            </ObservedData>
            <Co-occurrenceSet>
              <Zygosity>SingleHeterozygote</Zygosity>
              <AlleleDescSet>
                <Name>GCK:c.1253+8C&gt;T</Name>
                <Zygosity>SingleHeterozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>HNF4A:c.116-5C&gt;T</Name>
                <Zygosity>SingleHeterozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>TCF1:c.864G&gt;C</Name>
                <Zygosity>SingleHeterozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>TCF1:c.1545G&gt;A</Name>
                <Zygosity>SingleHeterozygote</Zygosity>
              </AlleleDescSet>
              <AlleleDescSet>
                <Name>TCF1:c.1720A&gt;G</Name>
                <Zygosity>Homozygote</Zygosity>
              </AlleleDescSet>
              <Count>1</Count>
            </Co-occurrenceSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TCF2" />
          </GeneList>
          <VariantType>single nucleotide variant</VariantType>
          <MolecularConsequenceList>
            <MolecularConsequence Function="frameshift mutation">
              <XRef DB="Sequence Ontology" ID="SO:0000865" />
            </MolecularConsequence>
          </MolecularConsequenceList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000458.2:c.477delT</Attribute>
          </AttributeSet>
          <AttributeSet>
            <Attribute Type="HGVS">p.Met160fsX1</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MODY5/RCAD</ElementValue>
            </Name>
            <Symbol>
              <ElementValue Type="Preferred">MODY5/RCAD</ElementValue>
            </Symbol>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5426783" TraitType="Disease" MappingType="XRef" MappingValue="137920" MappingRef="OMIM">
        <MedGen CUI="C0431693" Name="Renal cysts and diabetes syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1811300" TraitType="Disease" MappingType="Name" MappingValue="Renal cysts and diabetes syndrome" MappingRef="Preferred">
        <MedGen CUI="C0431693" Name="Renal cysts and diabetes syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5414725" TraitType="Disease" MappingType="XRef" MappingValue="137920" MappingRef="OMIM">
        <MedGen CUI="C0431693" Name="Renal cysts and diabetes syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5426783" TraitType="Disease" MappingType="XRef" MappingValue="125853" MappingRef="OMIM">
        <MedGen CUI="C0011860" Name="Type 2 diabetes mellitus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6132179" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5426783" TraitType="Disease" MappingType="XRef" MappingValue="144700" MappingRef="OMIM">
        <MedGen CUI="CN074294" Name="Nonpapillary renal cell carcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="57351" TraitType="Disease" MappingType="Name" MappingValue="MODY5/RCAD" MappingRef="Preferred">
        <MedGen CUI="C0431693" Name="Renal cysts and diabetes syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

